Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes

American Journal of Physiology - Renal Physiology

Volumn 288, Issue 1 57-1, 2005, Pages

  Foster, Rebecca R ^a   Saleem, Moin A ^a   Mathieson, Peter W ^a   Bates, David O ^a   Harper, Steven J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Filtration; Foot process; Glomerular filtration rate; Nephritis; VEGF

Indexed keywords

ANTIBODY; MONOCLONAL ANTIBODY; NEPHRIN; NEUTRALIZING ANTIBODY; PROTEIN KINASE B; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CELL IMMORTALIZATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNODETECTION; MUTATION; PODOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SERUM; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; WILD TYPE;

EID: 11144287218     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00146.2004     Document Type: Article

References (43)

1. Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, and Mercurio AM. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 61: 5736-5740, 2001.
2. Bailey E, Bottomley MJ, Westwell S, Pringle JH, Furness PN, Feehally J, Brenchley PE, and Harper SJ. Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by nonisotopic in situ hybridisation. J Clin Pathol 52: 735-738, 1999.
3. Bates DO and Curry FE. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am J Physiol Heart Circ Physiol 271: H2520-H2528, 1996.
4. Beltcheva O, Martin P, Lenkkeri U, and Tryggvason K. Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome. Hum Mutat 17: 368-373, 2001.
5. Bruckner K, Kockel L, Duchek P, Luque CM, Rorth P, and Perrimon N. The PDGF/VEGF receptor controls blood cell survival in Drosophila. Dev Cell 7: 73-84, 2004.
6. Cai J, Ahmad S, Jiang WG, Huang J, Kontos CD, Boulton M, and Ahmed A. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes 52: 2959-2968, 2003.
7. Casella I, Feccia T, Chelucci C, Samoggia P, Castelli G, Guerriero R, Parolini I, Petrucci E, Pelosi E, Morsilli O, Gabbianelli M, Testa U, and Peschle C. Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor. Blood 101: 1316-1323, 2003.
8. Chou MT, Wang J, and Fujita DJ. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells. BMC Biochem 3: 32, 2002.
9. 165b) mRNA and protein. Am J Physiol Renal Physiol 286: F767-F773, 2004.
10. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, and Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991, 1992.
11. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, and Quaggin SE. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716, 2003.
12. Forstreuter F, Lucius R, and Mentlein R. Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J Neuroimmunol 132: 93-98, 2002.
13. Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, and Harper SJ. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol 284: F1263-F1273, 2003.
14. Fujio Y and Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 274: 16349-16354, 1999.
15. Gerber HP, Malik AK, Solar GP, Sherman D, Liang XH, Meng G, Hong K, Marsters JC, and Ferrara N. VEGF regulates hematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417: 954-958, 2002.
16. Germani A, Di Carlo A, Mangoni A, Straino S, Giacinti C, Turrini P, Biglioli P, and Capogrossi MC. Vascular endothelial growth factor modulates skeletal myoblast function. Am J Pathol 163: 1417-1428, 2003.
17. Harper SJ, Xing CY, Whittle C, Parry R, Gillatt D, Peat D, and Mathieson PW. Expression of neuropilin-1 by human glomerular epithelial cells in vitro and in vivo. Clin Sci (Lond) 101: 439-446, 2001.
18. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A, Egger L, Lecha RL, Borner C, Pavenstadt H, Shaw AS, Walz G, and Benzing T. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol 23: 4917-4928, 2003.
19. Ito N, Huang K, and Claesson-Welsh L. Signal transduction by VEGF receptor-1 wild type and mutant proteins. Cell Signal 13: 849-854, 2001.
20. Jackson MW, Roberts JS, Heckford SE, Ricciardelli C, Stahl J, Choong C, Horsfall DJ, and Tilley WD. A potential autocrine role for vascular endothelial growth factor in prostate cancer. Cancer Res 62: 854-859, 2002.
21. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, and Tryggvason K. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1: 575-582, 1998.
22. Khoshnoodi J, Sigmundsson K, Ofverstedt LG, Skoglund U, Obrink B, Wartiovaara J, and Tryggvason K. Nephrin promotes cell-cell adhesion through homophilic interactions. Am J Pathol 163: 2337-2346, 2003.
23. Ku DD, Zaleski JK, Liu S, and Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol Heart Circ Physiol 265: H586-H592, 1993.
24. Lahdenpera J, Kilpelainen P, Liu XL, Pikkarainen T, Reponen P, Ruotsalainen V, and Tryggvason K. Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases. Kidney Int 64: 404-413, 2003.
25. Le Gouill S, Podar K, Amiot M, Hideshima T, Chauhan D, Itshitsuka K, Kumar S, Raje N, Richardson PG, Harousseau JL, and Anderson KC. VEGF induces MCL-1 upregulation and protects multiple myeloma cells against apoptosis. Blood 2004.
26. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
27. Lin MTYC and Kuo MC. Inhibition of VEGF-induced angiogenesis by Rosveratrol through interruption of Src-dependent vascular endothelium cadherin tyrosine phosphorylation. Mol Pharmacol 64: 1029-1036, 2003.
28. Liu G, Kaw B, Kurfis J, Rahmanuddin S, Kanwar YS, and Chugh SS. Nephl and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability. J Clin Invest 112: 209-221, 2003.
29. Liu L, Done SC, Khoshnoodi J, Bertorello A, Wartiovaara J, Berggren PO, and Tryggvason K. Defective nephrin trafficking caused by missense mutations in the NPHS1 gene: insight into the mechanisms of congenital nephrotic syndrome. Hum Mol Genet 10: 2637-2644, 2001.
30. 2-Adrenoceptor activation inhibits Shiga toxin2-induced apoptosis of renal tubular epithelial cells. Biochem Pharmacol 66: 343-353, 2003.
31. Ogunshola OO, Antic A, Donoghue MJ, Fan SY, Kim H, Stewart WB, Madri JA, and Ment LR. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem 277: 11410-11415, 2002.
32. O'Hare MJ, Bond J, Clarke C, Takeuchi Y, Atherton AJ, Berry C, Moody J, Silver AR, Davies DC, Alsop AE, Neville AM, and Jat PS. Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci USA 98: 646-651, 2001.
33. Quinn TP, Peters KG, De Vries C, Ferrara N, and Williams LT. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90: 7533-7537, 1993.
34. Reinders ME, Sho M, Izawa A, Wang P, Mukhopadhyay D, Koss KE, Geehan CS, Luster AD, Sayegh MH, and Briscoe DM. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 112: 1655-1665, 2003.
35. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, and Mundel P. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13: 630-638, 2002.
36. Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, Miner JH, and Shaw AS. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286: 312-315, 1999.
37. Sorensson J, Fierlbeck W, Heider T, Schwarz K, Park DS, Mundel P, Lisanti M, and Ballermann BJ. Glomerular endothelial fenestrae in vivo are not formed from caveolae. J Am Soc Nephrol 13: 2639-2647, 2002.
38. Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, and Kalluri R. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605-12608, 2003.
39. Thomas S, Vanuystel J, Gruden G, Rodriguez V, Burt D, Gnudi L, Hartley B, and Viberti G. Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J Am Soc Nephrol 11: 1236-1243, 2000.
40. Tryggvason K and Wartiovaara J. Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 10: 543-549, 2001.
41. Verma R, Wharram B, Kovari I, Kunkel R, Nihalani D, Wary KK, Wiggins RC, Killen P, and Holzman LB. Fyn binds to and phosphorylates the kidney slit diaphragm component Nephrin. J Biol Chem 278: 20716-20723, 2003.
42. Vermeulen K, Berneman ZN, and Van Bockstaele DR. Cell cycle and apoptosis. Cell Prolif 36: 165-175, 2003.
43. 165b, and inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. In press.